Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
(2000) · PubMed · Cited by 13,173 · see citing works
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791 · see citing works
Self-citationYounossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781 · see citing works
Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., Amtmann, D., Bode, R., Buysse, D., Choi, S., et al. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.011 · Cited by 5,128 · see citing works
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · see citing works
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987 · see citing works
McPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,059 · see citing works
Self-citationLazo, M., Hernáez, R., Eberhardt, M. S., Bonekamp, S., Kamel, I. R., Güallar, E., Koteish, A. A., Brancati, F. L., & Clark, J. M. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws448 · Cited by 796 · see citing works
Nonalcoholic fatty liver disease
Brunt, E., Wong, V., Nobili, V., Day, C., Sookoian, S., Maher, J., Bugianesi, E., Sirlin, C., Neuschwander-Tetri, B., & Rinella, M. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.80 · Cited by 591 · see citing works
Self-citationSanyal, A. J., Friedman, S. L., McCullough, A. J., & Dimick‐Santos, L. (2014) · Hepatology · doi:10.1002/hep.27678 · Cited by 355 · see citing works
Self-citationOral Glucose Tolerance Test Minimal Model Indexes of β-Cell Function and Insulin Sensitivity
Breda, E., Cavaghan, M. K., Toffolo, G., Polonsky, K. S., & Cobelli, C. (2001) · Diabetes · doi:10.2337/diabetes.50.1.150 · Cited by 320 · see citing works
Non-Alcoholic Fatty Liver Disease in Older People
Frith, J., Day, C. P., Henderson, E., Burt, A. D., & Newton, J. L. (2009) · Gerontology · doi:10.1159/000235677 · Cited by 280 · see citing works
Dunn, W., Sanyal, A. J., Brunt, E. M., Ünalp–Arida, A., Donohue, M., McCullough, A. J., & Schwimmer, J. B. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.03.024 · Cited by 276 · see citing works
Self-citationBower, G., Toma, T., Harling, L., Jiao, L. R., Efthimiou, E., Darzi, A. W., Athanasiou, T., & Ashrafian, H. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1691-x · Cited by 255 · see citing works
Genetic Factors That Affect Risk of Alcoholic and Nonalcoholic Fatty Liver Disease
Anstee, Q. M., Seth, D., & Day, C. P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.037 · Cited by 252 · see citing works
Self-citationSiddiqui, M. S., Harrison, S. A., Abdelmalek, M. F., Anstee, Q. M., Bédossa, P., Castéra, L., Dimick‐Santos, L., Friedman, S. L., Greene, K., Kleiner, D. E., et al. (2017) · Hepatology · doi:10.1002/hep.29607 · Cited by 165 · see citing works
Self-citationQuality of life in adults with nonalcoholic fatty liver disease
David, K., Kowdley, K. V., Ünalp, A., Kanwal, F., Brunt, E. M., & Schwimmer, J. B. (2009) · Hepatology · doi:10.1002/hep.22868 · Cited by 161 · see citing works
Liu, Y., Dai, M., Bi, Y., Xu, M., Xu, Y., Li, M., Wang, T., Huang, F., Xu, B., Zhang, J., et al. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20120067 · Cited by 132 · see citing works
Racial differences in nonalcoholic fatty liver disease in the U.S. population
Schneider, A. L. C., Lazo, M., Selvin, E., & Clark, J. M. (2013) · Obesity · doi:10.1002/oby.20426 · Cited by 127 · see citing works
Drug-induced liver injury in obesity
Fromenty, B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.018 · Cited by 94 · see citing works
Role of Cannabinoids in the Development of Fatty Liver (Steatosis)
Purohit, V., Rapaka, R. S., & Shurtleff, D. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9178-0 · Cited by 69 · see citing works
Measurement of Lifetime Alcohol Intake: Utility of a Self-administered Questionnaire
Friesema, I. H. M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh102 · Cited by 49 · see citing works
Review article: nonalcoholic fatty liver disease and hepatitis C virus – partners in crime
BLONSKY, J. J., & Harrison, S. A. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03672.x · Cited by 28 · see citing works
Miller, V. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.140 · Cited by 14 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of NAFLD development and therapeutic strategies
Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M., & Sanyal, A. J. (2018) · Nature Medicine · doi:10.1038/s41591-018-0104-9 · Cited by 4,354 · see citing works
Self-citationPast, present and future perspectives in nonalcoholic fatty liver disease
Sanyal, A. J. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0144-8 · Cited by 522 · see citing works
Self-citationCigarette smoking and liver diseases
Marti-Aguado, D., Clemente-Sanchez, A., & Bataller, R. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.016 · Cited by 190 · see citing works
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Wang, S., & Friedman, S. L. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0759 · Cited by 158 · see citing works
Glass, O., Filozof, C., Noureddin, M., Berner-Hansen, M., Schabel, E., Omokaro, S. O., Schattenberg, J. M., Barradas, K., Miller, V., Francque, S., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.04.030 · Cited by 89 · see citing works
Self-citation
- Authors
- Patel, Y. A., Imperial, J. C., Muir, A. J., Anstee, Q. M., DeBrota, D., Dimick-Santos, L., Filozof, C., Mehta, R., Sanyal, A. J., Schabel, E., Neuschwander-Tetri, B. A., Miller, V., Anstee, Q. M., Bangma, S., Baxter, M., Boulos, S., Burgess, G., Chakravarthy, M., Christian, R., Coombs, A., DeBrota, D., Dimick-Santos, L., Filozof, C., Gannedahl, G., Herrmann, R., Hum, D., Imperial, J., Kendrick, S., MacConell, L., Megnien, S., Mehta, R., Miller, V., Muir, A., Neuschwander-Tetri, B. A., Patel, Y., Peres, D., Rossi, S., Sanyal, A., Schabel, E., Shapiro, D., St Pierre, T., & Zemel, M.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 153
- Issue
- 3
- Pages
- 621-625.e7
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC5861348
- OpenAlex
- W2741217510
- Cited by
- 25
- References
- 25
- Citations by year
- 2024: 2 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 7 · 2018: 4
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007568)
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Keywords
- nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, baseline parameters, clinical trial design, liver fibrosis, drug development, chronic liver disease
- MeSH terms
- Biopsy, Clinical Trials as Topic, Eligibility Determination, Female, Humans, Life Style, Liver Function Tests, Male, Predictive Value of Tests, Research Design, Risk Factors, Sex Factors, Comorbidity, Treatment Outcome, Patient Selection, Polypharmacy, Genetic Predisposition to Disease, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
